Company: WFC-PC
Filing Date: 2025-04-29
Form Type: 10-Q
Source: 0000072971-25-000129
Chunk: 115

Company: WELLS FARGO & COMPANY/MN
Filing Date: 2025-04-29
Form: 10-Q
Item: Item 4
Chunk 115
---
 and Losses Not Held for TradingTable 4.2 provides a summary of the net gains and losses from equity securities not held for trading, which excludes equity method adjustments for our share of the investee’s earnings or losses that are recognized in other noninterest income. Gains and losses for securities held for trading are reported in net gains from trading and securities.Table 4.2:  Net Gains (Losses) from Equity Securities Not Held for TradingQuarter ended March 31,(in millions)20252024Net gains (losses) from equity securities carried at fair value$(195)11 Net gains (losses) from equity securities not carried at fair value (1):Impairment write-downs(194)(197)Net unrealized gains (2)1 127 Net realized gains45 77 Total net gains (losses) from equity securities not carried at fair value(148)7 Total net gains (losses) from equity securities not held for trading$(343)18 (1)Includes amounts related to venture capital investments in consolidated portfolio companies, which are not reported in equity securities on our consolidated balance sheet.(2)Includes unrealized gains (losses) due to observable price changes from equity securities accounted for under the measurement alternative.

Wells Fargo & Company67

Note 4:  Equity Securities (continued)

Measurement AlternativeTable 4.3 provides additional information about the impairment write-downs and observable price changes from nonmarketable equity securities accounted for under the measurement alternative. Gains and losses related to these adjustments are also included in Table 4.2.Table 4.3:  Net Gains (Losses) from Measurement Alternative Equity SecuritiesQuarter ended March 31,(in millions)20252024Net gains (losses) recognized in earnings during the period:Gross unrealized gains from observable price changes$43 127 Gross unrealized losses from observable price changes(25)— Impairment write-downs(165)(169)Net realized gains from sale15 62 Total net gains (losses) recognized during the period$(132)20 Table 4.4 presents cumulative carrying value adjustments to nonmarketable equity securities accounted for under the measurement alternative that were still held at the end of each reporting period presented.Table 4.4:  Measurement Alternative Cumulative Gains (Losses)(in millions) Mar 31,2025Dec 31,2024Cumulative gains (losses):Gross unrealized